semaglutide tablets patent expiry Last week's of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions As the patent for semaglutide,

Preliminary research, including a small randomised controlled trial published in Obesity (Robert et al., 2023), examined liraglutide in adults with binge eating disorder and obesity

Polyphenol-Rich Foods Polyphenol-rich foods like berries, dark chocolate, and green tea contain bioactive compounds that may help prolong natural GLP-1 activity by supporting gut microbiota and metabolic pathways linked with hormone regulation

Expert Review of Neurotherapeutics

Key warning signs requiring urgent evaluation include: Postmenopausal bleeding (any vaginal bleeding occurring more than 12 months after the last menstrual period) Bleeding accompanied by fever, unusual vaginal discharge, or pelvic pain suggesting infection Bleeding associated with pregnancy or suspected pregnancy Recurrent spotting that persists for more than two to three menstrual cycles Patients taking tirzepatide who develop abnormal bleeding should undergo a comprehensive gynecological assessment, including detailed menstrual history, pelvic examination, and pregnancy testing for all reproductive-age women regardless of contraceptive use

Keeping TSH within the target range helps prevent symptoms like fatigue, cold intolerance, or palpitations